The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...macies and primary healthcare facilities) and in
hospital settings, as well as for pharmacists working as clinical biologists in medical
analysis laboratories, for example, as clinical biologists, and offer a set of references that
may be consulted for more informationstor
more
INT J TUBERC LUNG DIS 22(2):197–205 http://dx.doi.org/10.5588/ijtld.17.0245
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Pan African Medical Journal 2017;27:215. doi: 10.11604/pamj.2017.27.215.12994
WG Implementation Guidelines Tool2
Published: April 26, 2017 https://doi.org/10.1371/journal.pone.0176004
ACAPS Briefing Note: Zika virus epidemic
Antimicrobial Resistance and Infection Control 2014,3 :31
Venturini et al. BMC Infectious Diseases 2014, 14(Suppl 1):S5 http://www.biomedcentral.com/1471-2334/14/S1/S5
PLoS Pathogens | www.plospathogens.org 1
February 2012 | Volume 8 | Issue 2 | e100246
UNAIDS/10.03E / JC1767E (English original, March 2010) ISBN 978 92 9 173849 6